Moderna, Inc. , a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally.
Moderna stock last closed at $152.10, down 1.57% from the previous day, and has decreased 13.27% in one year. It has overperformed other stocks in the Biotechnology industry by 0.11 percentage points. Moderna stock is currently +32.23% from its 52-week low of $115.03, and -29.99% from its 52-week high of $217.25.
There are currently 386.34M shares of MRNA outstanding. The market value of MRNA is $58.76B. In the past 24 hours, 2.99M MRNA shares were traded.
You will need an online brokerage account to access the NASDAQ market and buy MRNA stock.
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your stock purchase by creating an account with eToro now.
Open eToro AccountNow that you've chosen the best brokerage, you'll need to fill out some personal information so you are able to buy MRNA today.
Now that you've filled out your info on the best stock trading app, you need to deposit funds:
Check out the tutorial below to see the process of transferring funds into your new investment account.
After you have figured out the best place to buy Moderna stock, it's crucial to research their stock prior to investing, so you can comprehend the risk as well as the opportunity.
WallStreetZen was created to help part-time investors do more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on MRNA's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge MRNA's fair value.
Using relative valuations ratios:
You can do more valuation analysis on MRNA's stock here.
Out of 11 sell side analysts who research MRNA, the consensus analyst rating on Moderna is a Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Tyler Van Buren, a bottom 6% analyst from TD Cowen upgrades MRNA to a buy rating and raises their MRNA price target from $150.00 to $180.00, on Mar 13, 2023.
Luca Issi, a bottom 2% analyst from RBC Capital initiates coverage on MRNA with a buy rating and announces their MRNA price target of $200.00, on Mar 2, 2023.
Emmanuel Papadakis, a top 28% analyst from Deutsche Bank maintains MRNA with a strong buy rating and lowers their MRNA price target from $225.00 to $200.00, on Feb 28, 2023.
Mani Foroohar, a bottom 1% analyst from SVB Leerink downgrades MRNA to a sell rating and lowers their MRNA price target from $111.00 to $93.00, on Feb 24, 2023.
Jessica Fye, a top 11% analyst from JP Morgan maintains MRNA with a hold rating and raises their MRNA price target from $132.00 to $138.00, on Feb 8, 2023.
You can dig deeper into what analysts are forecasting on the Moderna stock forecast page.
Last year, MRNA earnings were $8.36B. Over the past 1 years, MRNA's earnings have grown by -29.86% per year. This was slower than the Biotechnology industry average of 9.38%.
Last year, MRNA revenue was $19.26B. During the past five year, MRNA's revenue has grown by 147.88% per year. This was faster than the Biotechnology industry average of 50.9%.
Learn more about MRNA's earnings and revenue performance here.
Over the last year, insiders at MRNA have sold more shares than they have bought.
Stephane Bancel, Chief Executive Officer of MRNA, was the latest MRNA insider to sell. They sold $559,333.32 worth of MRNA shares on Mar 16, 2023.
Dig into more about who owns MRNA shares here.
No, Moderna doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
You have two primary options:
Click the Open button and eToro will execute your order.
If you need more help investing in stocks on eToro, click the how to video below:
Now that you own some MRNA stock, you'll want to keep up with your investment.
Create a watchlist to monitor your MRNA stock.
To summarize, here are the 6 steps to buy Moderna stock:
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Moderna, add MRNA to your watchlist below.